Carmat
Pierre Bastid has spent more than 25 years in senior executive positions at major international business groups such as Schlumberger, Schneider Electric, Valeo and Thomson. Former President and CEO of Converteam Group, acquired from Alstom, he developed and sold to General Electric after the value increased by 30. His fund ZAKA has especially invested in several biotechnology companies including Carmat and Cellectis of which he is Board member.
He first joined the Carmat Board of Directors on 5 April 2018.
This person is not in the org chart
This person is not in any offices
Carmat
CARMAT is a medical device company developing the world’s most advanced total artificial heart. CARMAT aims to eventually provide a response to a major public health issue associated with heart disease, the world’s leading cause of death: chronic and acute heart failure.